This inventor holds 1 USPTO granted patent. Top assignees: Xiamen University, Yang Sheng Tang Company Limited. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 165 
1 out of 13 Years Active: 2026
Title: Jiali Cao - Innovator in Antiviral Treatments
Introduction
Jiali Cao is a notable inventor based in Fujian, China. He has made significant contributions to the field of antiviral treatments, particularly in the fight against hepatitis B. His innovative approach has led to the development of a patent that addresses a critical health issue.
Latest Patents
Jiali Cao holds a patent for the "Use of palovarotene in treatment against HBV virus." This patent relates to the antiviral treatment of hepatitis B and specifically involves the use of a compound represented by a specific formula in combating the HBV virus. This advancement is crucial for improving treatment options for patients suffering from this viral infection.
Career Highlights
Throughout his career, Jiali Cao has worked with reputable organizations, including Yang Sheng Tang Company Limited and Xiamen University. His experience in these institutions has allowed him to develop his expertise in antiviral research and treatment methodologies.
Collaborations
Jiali Cao has collaborated with Tianshu Shi, a fellow researcher in the field. Their partnership has contributed to the advancement of knowledge and innovation in antiviral treatments.
Conclusion
Jiali Cao's work in developing antiviral treatments showcases his commitment to improving public health. His patent on the use of palovarotene against the HBV virus represents a significant step forward in the fight against hepatitis B.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile